
CAS: 2001559-19-7

6-(4-(3-Chloro-4-fluorophenyl)-1-(2-hydroxyethyl)-1H-imidazol-5-yl)imidazo[1,2-b]pyridazine-3-carbonitrile
CAS:2001559-19-7
Formula:
C18H12ClFN6O
Purity:
97%
Color and Shape:
Solid
Molecular weight:
382.7789
Ref: IN-DA01KJZS
1mg | 63.00 € | ||
5mg | 113.00 € | ||
10mg | 166.00 € | ||
25mg | 203.00 € | ||
50mg | 331.00 € | ||
100mg | 523.00 € |
Estimated delivery in United States, on Tuesday 15 Apr 2025

Ref: 54-BUP03048
25mg | 563.00 € | ||
50mg | 835.00 € | ||
100mg | 1,182.00 € |
Estimated delivery in United States, on Monday 14 Apr 2025

6-(4-(3-Chloro-4-Fluorophenyl)-1-(2-Hydroxyethyl)-1H-Imidazol-5-Yl)Imidazo[1,2-B]Pyridazine-3-Carbonitrile
CAS:2001559-19-7
Purity:
97%
Molecular weight:
382.78g/mol
Ref: 54-PC108581
100mg | 548.00 € | ||
250mg | 1,077.00 € |
Estimated delivery in United States, on Monday 14 Apr 2025

BMS986260
CAS:2001559-19-7
BMS-986260 is a selective, and orally bioavailable TGFβR1 inhibitor(IC50 = 1.6 nM).
Formula:
C18H12ClFN6O
Purity:
97.67%
Color and Shape:
Solid
Molecular weight:
382.78
Ref: TM-T8730
1mg | 88.00 € | ||
5mg | 160.00 € | ||
10mg | 230.00 € | ||
25mg | 378.00 € | ||
50mg | 568.00 € | ||
100mg | 805.00 € | ||
1mL*10mM (DMSO) | 188.00 € |
Estimated delivery in United States, on Tuesday 22 Apr 2025

6-(4-(3-Chloro-4-fluorophenyl)-1-(2-hydroxyethyl)-1H-imidazol-5-yl)imidazo[1,2-b]pyridazine-3-carbonitrile
CAS:2001559-19-7
Please enquire for more information about 6-(4-(3-Chloro-4-fluorophenyl)-1-(2-hydroxyethyl)-1H-imidazol-5-yl)imidazo[1,2-b]pyridazine-3-carbonitrile including the price, delivery time and more detailed …
Formula:
C18H12ClFN6O
Purity:
Min. 95%
Molecular weight:
382.8 g/mol
Ref: 3D-BFD55919
50mg | 1,042.00 € | ||
100mg | 1,366.00 € |
Estimated delivery in United States, on Tuesday 27 May 2025